Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Ryanair Holdings Q1 Earnings

  Ryanair Holdings (NASDAQ:RYAAY) reported its Q1 earnings results on Monday, July 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
July 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Ryanair Holdings (NASDAQ:RYAAY) reported its Q1 earnings results on Monday, July 25, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Ryanair Holdings beat estimated earnings by 66.04%, reporting an EPS of $0.88 versus an estimate of $0.53.

Revenue was up $2.33 billion from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.54 which was followed by a 4.44% increase in the share price the next day.

 

To track all earnings releases for Ryanair Holdings visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GSK Announced Blenrep DREAMM-3 Phase III Did Not Meet Primary Endpoint of Progression-free Survival

By Charles Gross
November 7, 6:05 AM
GSK plc (LSE/NYSE: GSK) today announced that DREAMM-3, the phase III open-label, randomised head-to-head superiority trial of Blenrep (belantamab mafodotin) monotherapy versus pomalidomide in combination with low dose dexamethasone (PomDex) in patients with relapsed or refractory multiple myeloma (RRMM), did not meet its primary endpoint of progression-free survival (PFS).

GSK